European IVD Companies See Worrying Trend In Market Access Barriers
Are medtech regulators and authorities in wider Europe – including Russia – setting market access barriers too high, risking investment in innovation and potentially denying patients access to modern care? European Diagnostic Manufacturers Association (EDMA) representative Christian Parry fears so, in this second half of our industry update from the 2015 European MedTech Forum.
You may also be interested in...
A key stage in the EU process of adopting and implementing new regulations for medical devices and diagnostics was reached with the recent series of debates – the Trilogues – between the European Commission, the Parliament and Council of the EU. But matters are poised on a knife edge and are not always moving as quickly as or in the way local industry wants.
Norway’s Pre Diagnostics uses the intracellular approach to neurodegenerative disease diagnosis. It believes its technology will open up a world of precision medicine for Alzheimer’s disease patients.
Device sales centers are being required to update the government’s product tracking system with sales data under a series of recent changes spurred partly by COVID-19.